Metformin monotherapy in lean women with polycystic ovary syndrome

Author： Kumari AS   Haq A   Jayasundaram R   Abdel-Wareth LO   al Haija SA   Alvares M  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.10, Iss.1, 2005-01, pp. : 100-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 1, 2014-06 ,pp. : 70-83

Bentham Science Publishers

Access to resources Recommend Favorite

Metformin in the Treatment of Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2121-2125

Bentham Science Publishers

Access to resources Recommend Favorite

As adjuncts to diet, flutamide and metformin provide long-term, complementary benefits in overweight-obese women with polycystic ovary syndrome

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Short-term dexamethasone can further reduce androgen levels in women with polycystic ovary syndrome treated with metformin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

The oral insulin sensitiser INS-1 improves ovulation and has beneficial cardiovascular effects in lean women with polycystic ovary syndrome

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite